One Capital Management LLC Buys New Position in Privia Health Group, Inc. $PRVA

One Capital Management LLC bought a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 44,291 shares of the company’s stock, valued at approximately $1,050,000.

Other hedge funds also recently modified their holdings of the company. Hantz Financial Services Inc. lifted its position in shares of Privia Health Group by 456.2% in the 4th quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after acquiring an additional 926 shares during the period. Global Retirement Partners LLC lifted its position in shares of Privia Health Group by 579.8% in the 4th quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after acquiring an additional 1,351 shares during the period. Canada Pension Plan Investment Board lifted its position in shares of Privia Health Group by 48.0% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock worth $85,000 after acquiring an additional 1,200 shares during the period. GAMMA Investing LLC lifted its position in shares of Privia Health Group by 198.5% in the 4th quarter. GAMMA Investing LLC now owns 4,314 shares of the company’s stock worth $102,000 after acquiring an additional 2,869 shares during the period. Finally, Raymond James Financial Inc. bought a new stake in shares of Privia Health Group in the 2nd quarter worth approximately $113,000. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Price Performance

Shares of PRVA opened at $20.66 on Thursday. The company has a market capitalization of $2.60 billion, a P/E ratio of 129.13, a PEG ratio of 1.67 and a beta of 0.90. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $26.51. The business’s 50 day simple moving average is $22.61 and its 200-day simple moving average is $23.00.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.11. The firm had revenue of $603.85 million during the quarter, compared to the consensus estimate of $560.99 million. Privia Health Group had a return on equity of 2.81% and a net margin of 0.97%.The business’s revenue for the quarter was up 25.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.22 EPS. On average, sell-side analysts anticipate that Privia Health Group, Inc. will post 0.32 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on the company. Canaccord Genuity Group reduced their price objective on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Weiss Ratings downgraded Privia Health Group from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 8th. Jefferies Financial Group reiterated a “buy” rating and issued a $32.00 price objective on shares of Privia Health Group in a research report on Thursday, February 26th. Evercore set a $26.00 price objective on Privia Health Group in a research report on Wednesday, April 8th. Finally, Citigroup reduced their price objective on Privia Health Group from $34.00 to $32.00 and set a “buy” rating for the company in a research report on Tuesday, March 3rd. Eleven research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $31.15.

Insiders Place Their Bets

In other Privia Health Group news, Director Matthew Shawn Morris sold 17,096 shares of the business’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $24.99, for a total value of $427,229.04. Following the transaction, the director owned 68,188 shares of the company’s stock, valued at approximately $1,704,018.12. The trade was a 20.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Mountcastle sold 7,179 shares of the business’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $25.03, for a total value of $179,690.37. Following the completion of the transaction, the chief financial officer directly owned 214,847 shares in the company, valued at approximately $5,377,620.41. This represents a 3.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 361,330 shares of company stock valued at $8,172,284. 5.70% of the stock is currently owned by corporate insiders.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.